Overall, our data indicate that colon cancer-associated ADAM17 variants (E319G, E406X, M435I) exhibit diminished substrate recognition and/or enzymatic activity towards physiological substrates of the metalloprotease (TNFα, IL-6R, AREG). This evidence concerns the gene IL6R and malignant colon neoplasm.